nach oben

Irish Journal of Medical Science (1971 -)

Erschienen in:

15.01.2019 | Review Article

Obesity cardiomyopathy: the role of obstructive sleep apnea and obesity hypoventilation syndrome

verfasst von: William Newmarch, Madina Weiler, Brian Casserly

Erschienen in: Irish Journal of Medical Science (1971 -) | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

The negative long-term health consequences of obesity are well known to both the medical profession and general public. Despite this, the number of obese and overweight individuals worldwide continues to steadily rise. Although obesity has long been associated with an increased risk for cardiovascular disease and mortality, the classification of a cardiomyopathy of obesity is a more recent development. Obesity cardiomyopathy is characterized as myocardial dysfunction or heart failure in obese individuals independent of other cardiovascular risk factors. The purpose of this report is to provide an overview of obesity cardiomyopathy and the proposed pathophysiological mechanisms underlying this disease, as well as to examine the link between obesity cardiomyopathy and sleep-related disorders.

World Health Organization (WHO). Obesity Fact Sheet 2016 [Available from: http://www.who.int/mediacentre/factsheets/fs311/en/

Bray GA, Perreault L. Obesity in adults: health consequences. In: Post T, editor. UpToDate. UpToDate, Waltham. Accessed on July 28, 2017

McTigue K, Larson JC, Valoski A, Burke G, Kotchen J, Lewis CE, Stefanick ML, van Horn L, Kuller L (2006) Mortality and cardiac and vascular outcomes in extremely obese women. JAMA 296(1):79–86CrossRefPubMed

Gu D, He J, Duan X, Reynolds K, Wu X, Chen J, Huang G, Chen CS, Whelton PK (2006) Body weight and mortality among men and women in China. JAMA 295(7):776–783CrossRefPubMed

Yan LL, Daviglus ML, Liu K, Stamler J, Wang R, Pirzada A, Garside DB, Dyer AR, van Horn L, Liao Y, Fries JF, Greenland P (2006) Midlife body mass index and hospitalization and mortality in older age. JAMA 295(2):190–198CrossRefPubMed

Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, Hollenbeck A, Leitzmann MF (2006) Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 355(8):763–778CrossRefPubMed

Jee SH, Sull JW, Park J, Lee SY, Ohrr H, Guallar E, Samet JM (2006) Body-mass index and mortality in Korean men and women. N Engl J Med 355(8):779–787CrossRefPubMed

Freedman DM, Ron E, Ballard-Barbash R, Doody MM, Linet MS (2006) Body mass index and all-cause mortality in a nationwide US cohort. Int J Obes 30(5):822–829CrossRef

Price GM, Uauy R, Breeze E, Bulpitt CJ, Fletcher AE (2006) Weight, shape, and mortality risk in older persons: elevated waist-hip ratio, not high body mass index, is associated with a greater risk of death. Am J Clin Nutr 84(2):449–460CrossRefPubMed

10.

Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K, van der Schouw YT, Spencer E, Moons KGM, Tjønneland A, Halkjaer J, Jensen MK, Stegger J, Clavel-Chapelon F, Boutron-Ruault MC, Chajes V, Linseisen J, Kaaks R, Trichopoulou A, Trichopoulos D, Bamia C, Sieri S, Palli D, Tumino R, Vineis P, Panico S, Peeters PHM, May AM, Bueno-de-Mesquita HB, van Duijnhoven FJB, Hallmans G, Weinehall L, Manjer J, Hedblad B, Lund E, Agudo A, Arriola L, Barricarte A, Navarro C, Martinez C, Quirós JR, Key T, Bingham S, Khaw KT, Boffetta P, Jenab M, Ferrari P, Riboli E (2008) General and abdominal adiposity and risk of death in Europe. N Engl J Med 359(20):2105–2120CrossRefPubMed

11.

Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J et al (2009) Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 373(9669):1083–1096CrossRefPubMed

12.

Flegal KM, Graubard BI, Williamson DF, Gail MH (2007) Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 298(17):2028–2037CrossRefPubMed

13.

Tobias DK, Pan A, Jackson CL, O'Reilly EJ, Ding EL, Willett WC, Manson JAE, Hu FB (2014) Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med 370(3):233–244CrossRefPubMedPubMedCentral

14.

Kramer CK, Zinman B, Retnakaran R (2013) Are metabolically healthy overweight and obesity benign conditions?: a systematic review and meta-analysis. Ann Intern Med 159(11):758–769CrossRefPubMed

15.

Aune D, Sen A, Prasad M, Norat T, Janszky I, Tonstad S et al (2016) BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants. BMJ 353:i2156CrossRefPubMedPubMedCentral

16.

Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M (2011) Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 378(9793):815–825CrossRefPubMed

17.

Nguyen NT, Magno CP, Lane KT, Hinojosa MW, Lane JS (2008) Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and nutrition examination survey, 1999 to 2004. J Am Coll Surg 207(6):928–934CrossRefPubMed

18.

Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH, American Heart Association., Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism (2006) Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association scientific statement on obesity and heart disease from the obesity Committee of the Council on nutrition, physical activity, and metabolism. Circulation 113(6):898–918CrossRefPubMed

19.

Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG et al (2002) Obesity and the risk of heart failure. N Engl J Med 347(5):305–313CrossRefPubMed

20.

Wong C, Marwick TH (2007) Obesity cardiomyopathy: pathogenesis and pathophysiology. Nat Clin Pract Cardiovasc Med 4(8):436–443CrossRefPubMed

21.

Young T, Skatrud J, Peppard PE (2004) Risk factors for obstructive sleep apnea in adults. JAMA 291(16):2013–2016CrossRefPubMed

22.

Peppard PE, Young T, Palta M, Dempsey J, Skatrud J (2000) Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 284(23):3015–3021CrossRefPubMed

23.

Tufik S, Santos-Silva R, Taddei JA, Bittencourt LR (2010) Obstructive sleep apnea syndrome in the Sao Paulo epidemiologic sleep study. Sleep Med 11(5):441–446CrossRefPubMed

24.

Povitz M, James MT, Pendharkar SR, Raneri J, Hanly PJ, Tsai WH (2015) Prevalence of sleep-disordered breathing in obese patients with chronic hypoxemia. A cross-sectional study. Ann Am Thorac Soc 12(6):921–927CrossRefPubMed

25.

Myers KA, Mrkobrada M, Simel DL (2013) Does this patient have obstructive sleep apnea?: the rational clinical examination systematic review. JAMA 310(7):731–741CrossRefPubMed

26.

Mokhlesi B, Finn LA, Hagen EW, Young T, Hla KM, Van Cauter E et al (2014) Obstructive sleep apnea during REM sleep and hypertension. Results of the Wisconsin sleep cohort. Am J Respir Crit Care Med 190(10):1158–1167CrossRefPubMedPubMedCentral

27.

Grimaldi D, Beccuti G, Touma C, Van Cauter E, Mokhlesi B (2014) Association of obstructive sleep apnea in rapid eye movement sleep with reduced glycemic control in type 2 diabetes: therapeutic implications. Diabetes Care 37(2):355–363CrossRefPubMedPubMedCentral

28.

Punjabi NM, Caffo BS, Goodwin JL, Gottlieb DJ, Newman AB, O'Connor GT, Rapoport DM, Redline S, Resnick HE, Robbins JA, Shahar E, Unruh ML, Samet JM (2009) Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 6(8):e1000132CrossRefPubMedPubMedCentral

29.

Gottlieb DJ, Yenokyan G, Newman AB, O'Connor GT, Punjabi NM, Quan SF, Redline S, Resnick HE, Tong EK, Diener-West M, Shahar E (2010) Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation 122(4):352–360CrossRefPubMedPubMedCentral

30.

Cadby G, McArdle N, Briffa T, Hillman DR, Simpson L, Knuiman M, Hung J (2015) Severity of OSA is an independent predictor of incident atrial fibrillation hospitalization in a large sleep-clinic cohort. Chest 148(4):945–952CrossRefPubMed

31.

Redline S, Yenokyan G, Gottlieb DJ, Shahar E, O'Connor GT, Resnick HE, Diener-West M, Sanders MH, Wolf PA, Geraghty EM, Ali T, Lebowitz M, Punjabi NM (2010) Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am J Respir Crit Care Med 182(2):269–277CrossRefPubMedPubMedCentral

32.

Hla KM, Young T, Hagen EW, Stein JH, Finn LA, Nieto FJ, Peppard PE (2015) Coronary heart disease incidence in sleep disordered breathing: the Wisconsin sleep cohort study. Sleep 38(5):677–684CrossRefPubMedPubMedCentral

33.

Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, Daniels S, Floras JS, Hunt CE, Olson LJ, Pickering TG, Russell R, Woo M, Young T (2008) Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation scientific statement from the American Heart Association Council for high blood pressure research professional education committee, council on clinical cardiology, stroke council, and council on cardiovascular nursing. J Am Coll Cardiol 52(8):686–717CrossRefPubMed

34.

Querejeta Roca G, Redline S, Punjabi N, Claggett B, Ballantyne CM, Solomon SD et al (2013) Sleep apnea is associated with subclinical myocardial injury in the community. The ARIC-SHHS study. Am J Respir Crit Care Med 188(12):1460–1465CrossRefPubMed

35.

Mokhlesi B (2010) Obesity hypoventilation syndrome: a state-of-the-art review. Respir Care 55(10):1347–1362 discussion 63-5PubMed

36.

Piper AJ, Grunstein RR (2011) Obesity hypoventilation syndrome: mechanisms and management. Am J Respir Crit Care Med 183(3):292–298CrossRefPubMed

37.

Nowbar S, Burkart KM, Gonzales R, Fedorowicz A, Gozansky WS, Gaudio JC, Taylor MRG, Zwillich CW (2004) Obesity-associated hypoventilation in hospitalized patients: prevalence, effects, and outcome. Am J Med 116(1):1–7CrossRefPubMed

38.

Perez de Llano LA, Golpe R, Ortiz Piquer M, Veres Racamonde A, Vazquez Caruncho M, Caballero Muinelos O et al (2005) Short-term and long-term effects of nasal intermittent positive pressure ventilation in patients with obesity-hypoventilation syndrome. Chest 128(2):587–594CrossRefPubMed

39.

Marik PE, Desai H (2013) Characteristics of patients with the “malignant obesity hypoventilation syndrome” admitted to an ICU. J Intensive Care Med 28(2):124–130CrossRefPubMed

40.

Borel JC, Burel B, Tamisier R, Dias-Domingos S, Baguet JP, Levy P, Pepin JL (2013) Comorbidities and mortality in hypercapnic obese under domiciliary noninvasive ventilation. PLoS One 8(1):e52006CrossRefPubMedPubMedCentral

41.

Castro-Anon O, Perez de Llano LA, De la Fuente Sanchez S, Golpe R, Mendez Marote L, Castro-Castro J et al (2015) Obesity-hypoventilation syndrome: increased risk of death over sleep apnea syndrome. PLoS One 10(2):e0117808CrossRefPubMedPubMedCentral

42.

Trakada GP, Steiropoulos P, Nena E, Constandinidis TC, Bouros D (2010) Prevalence and clinical characteristics of obesity hypoventilation syndrome among individuals reporting sleep-related breathing symptoms in northern Greece. Sleep Breath 14(4):381–386CrossRefPubMed

43.

Hubert HB, Feinleib M, McNamara PM, Castelli WP (1983) Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham heart study. Circulation 67(5):968–977CrossRefPubMed

44.

Chen YT, Vaccarino V, Williams CS, Butler J, Berkman LF, Krumholz HM (1999) Risk factors for heart failure in the elderly: a prospective community-based study. Am J Med 106(6):605–612CrossRefPubMed

45.

Dwyer EM, Asif M, Ippolito T, Gillespie M (2000) Role of hypertension, diabetes, obesity, and race in the development of symptomatic myocardial dysfunction in a predominantly minority population with normal coronary arteries. Am Heart J 139(2 Pt 1):297–304CrossRefPubMed

46.

Fischer M, Baessler A, Hense HW, Hengstenberg C, Muscholl M, Holmer S, Döring A, Broeckel U, Riegger G, Schunkert H (2003) Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J 24(4):320–328CrossRefPubMed

47.

He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK (2001) Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 161(7):996–1002CrossRefPubMed

48.

Murphy NF, MacIntyre K, Stewart S, Hart CL, Hole D, McMurray JJ (2006) Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew-Paisley study). Eur Heart J 27(1):96–106CrossRefPubMed

49.

Dagenais GR, Yi Q, Mann JF, Bosch J, Pogue J, Yusuf S (2005) Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease. Am Heart J 149(1):54–60CrossRefPubMed

50.

Ashrafian H, le Roux CW, Darzi A, Athanasiou T (2008) Effects of bariatric surgery on cardiovascular function. Circulation 118(20):2091–2102CrossRefPubMed

51.

Karason K, Wallentin I, Larsson B, Sjostrom L (1997) Effects of obesity and weight loss on left ventricular mass and relative wall thickness: survey and intervention study. BMJ 315(7113):912–916CrossRefPubMedPubMedCentral

52.

Amad KH, Brennan JC, Alexander JK (1965) The cardiac pathology of chronic exogenous obesity. Circulation 32(5):740–745CrossRefPubMed

53.

Lauer MS, Anderson KM, Kannel WB, Levy D (1991) The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. JAMA 266(2):231–236CrossRefPubMed

54.

Alaud-din A, Meterissian S, Lisbona R, MacLean LD, Forse RA (1990) Assessment of cardiac function in patients who were morbidly obese. Surgery 108(4):809–818 discussion 18-20PubMed

55.

Nakajima T, Fujioka S, Tokunaga K, Hirobe K, Matsuzawa Y, Tarui S (1985) Noninvasive study of left ventricular performance in obese patients: influence of duration of obesity. Circulation 71(3):481–486CrossRefPubMed

56.

de Simone G, Devereux RB, Roman MJ, Alderman MH, Laragh JH (1994) Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension 23(5):600–606CrossRefPubMed

57.

Wong CY, O'Moore-Sullivan T, Leano R, Hukins C, Jenkins C, Marwick TH (2006) Association of subclinical right ventricular dysfunction with obesity. J Am Coll Cardiol 47(3):611–616CrossRefPubMed

58.

Wong CY, O'Moore-Sullivan T, Leano R, Byrne N, Beller E, Marwick TH (2004) Alterations of left ventricular myocardial characteristics associated with obesity. Circulation 110(19):3081–3087CrossRefPubMed

59.

de Divitiis O, Fazio S, Petitto M, Maddalena G, Contaldo F, Mancini M (1981) Obesity and cardiac function. Circulation 64(3):477–482CrossRefPubMed

60.

Ku CS, Lin SL, Wang DJ, Chang SK, Lee WJ (1994) Left ventricular filling in young normotensive obese adults. Am J Cardiol 73(8):613–615CrossRefPubMed

61.

Pascual M, Pascual DA, Soria F, Vicente T, Hernandez AM, Tebar FJ et al (2003) Effects of isolated obesity on systolic and diastolic left ventricular function. Heart 89(10):1152–1156CrossRefPubMedPubMedCentral

62.

Ferraro S, Perrone-Filardi P, Desiderio A, Betocchi S, D'Alto M, Liguori L et al (1996) Left ventricular systolic and diastolic function in severe obesity: a radionuclide study. Cardiology 87(4):347–353CrossRefPubMed

63.

Peterson LR, Waggoner AD, Schechtman KB, Meyer T, Gropler RJ, Barzilai B, Dávila-Román VG (2004) Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging. J Am Coll Cardiol 43(8):1399–1404CrossRefPubMed

64.

Tumuklu MM, Etikan I, Kisacik B, Kayikcioglu M (2007) Effect of obesity on left ventricular structure and myocardial systolic function: assessment by tissue Doppler imaging and strain/strain rate imaging. Echocardiography 24(8):802–809CrossRefPubMed

65.

Orhan AL, Uslu N, Dayi SU, Nurkalem Z, Uzun F, Erer HB, Hasdemir H, Emre A, Karakus G, Soran O, Gorcsan J III, Eren M (2010) Effects of isolated obesity on left and right ventricular function: a tissue Doppler and strain rate imaging study. Echocardiography 27(3):236–243CrossRefPubMed

66.

Alpert MA, Omran J, Bostick BP (2016) Effects of obesity on cardiovascular hemodynamics, cardiac morphology, and ventricular function. Curr Obes Rep 5(4):424–434CrossRefPubMed

67.

Alpert MA, Terry BE, Lambert CR, Kelly DL, Panayiotou H, Mukerji V, Massey CV, Cohen MV (1993) Factors influencing left ventricular systolic function in nonhypertensive morbidly obese patients, and effect of weight loss induced by gastroplasty. Am J Cardiol 71(8):733–737CrossRefPubMed

68.

Alpert MA, Lavie CJ, Agrawal H, Kumar A, Kumar SA (2016) Cardiac effects of obesity: PATHOPHYSIOLOGIC, CLINICAL, AND PROGNOSTIC CONSEQUENCES-A REVIEW. J Cardiopulm Rehabil Prev 36(1):1–11CrossRefPubMed

69.

Vasan RS (2003) Cardiac function and obesity. Heart 89(10):1127–1129CrossRefPubMedPubMedCentral

70.

Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH (2006) Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Arterioscler Thromb Vasc Biol 26(5):968–976CrossRefPubMed

71.

Alpert MA (2001) Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am J Med Sci 321(4):225–236CrossRefPubMed

72.

Alpert MA (2001) Management of obesity cardiomyopathy. Am J Med Sci 321(4):237–241CrossRefPubMed

73.

Lavie CJ, Milani RV, Ventura HO (2009) Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 53(21):1925–1932CrossRefPubMed

74.

Asghar O, Alam U, Hayat SA, Aghamohammadzadeh R, Heagerty AM, Malik RA (2012) Obesity, diabetes and atrial fibrillation; epidemiology, mechanisms and interventions. Curr Cardiol Rev 8(4):253–264CrossRefPubMedPubMedCentral

75.

Ebong IA, Goff DC Jr, Rodriguez CJ, Chen H, Sibley CT, Bertoni AG (2013) Association of lipids with incident heart failure among adults with and without diabetes mellitus: multiethnic study of atherosclerosis. Circ Heart Fail 6(3):371–378CrossRefPubMedPubMedCentral

76.

Schaffer JE (2003) Lipotoxicity: when tissues overeat. Curr Opin Lipidol 14(3):281–287CrossRefPubMed

77.

Chiu HC, Kovacs A, Ford DA, Hsu FF, Garcia R, Herrero P, Saffitz JE, Schaffer JE (2001) A novel mouse model of lipotoxic cardiomyopathy. J Clin Invest 107(7):813–822CrossRefPubMedPubMedCentral

78.

Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, Unger RH (2000) Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A 97(4):1784–1789CrossRefPubMedPubMedCentral

79.

Park TS, Hu Y, Noh HL, Drosatos K, Okajima K, Buchanan J, Tuinei J, Homma S, Jiang XC, Abel ED, Goldberg IJ (2008) Ceramide is a cardiotoxin in lipotoxic cardiomyopathy. J Lipid Res 49(10):2101–2112CrossRefPubMedPubMedCentral

80.

Kang SC, Kim BR, Lee SY, Park TS (2013) Sphingolipid metabolism and obesity-induced inflammation. Front Endocrinol (Lausanne) 4:67CrossRef

81.

Ingelsson E, Sundstrom J, Arnlov J, Zethelius B, Lind L (2005) Insulin resistance and risk of congestive heart failure. JAMA 294(3):334–341CrossRefPubMed

82.

Banerjee S, Peterson LR (2007) Myocardial metabolism and cardiac performance in obesity and insulin resistance. Curr Cardiol Rep 9(2):143–149CrossRefPubMed

83.

Peterson LR, Herrero P, Schechtman KB, Racette SB, Waggoner AD, Kisrieva-Ware Z, Dence C, Klein S, Marsala JA, Meyer T, Gropler RJ (2004) Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation 109(18):2191–2196CrossRefPubMed

84.

Turer AT, Hill JA, Elmquist JK, Scherer PE (2012) Adipose tissue biology and cardiomyopathy: translational implications. Circ Res 111(12):1565–1577CrossRefPubMedPubMedCentral

85.

Goodfriend TL, Kelley DE, Goodpaster BH, Winters SJ (1999) Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women. Obes Res 7(4):355–362CrossRefPubMed

86.

Dela Cruz CS, Matthay RA (2009) Role of obesity in cardiomyopathy and pulmonary hypertension. Clin Chest Med 30(3):509–523 ix CrossRef

87.

Karmazyn M, Purdham DM, Rajapurohitam V, Zeidan A (2008) Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart. Cardiovasc Res 79(2):279–286CrossRefPubMed

88.

Dunbar JC, Hu Y, Lu H (1997) Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes 46(12):2040–2043CrossRefPubMed

89.

Lavie CJ, Mehra MR, Milani RV (2005) Obesity and heart failure prognosis: paradox or reverse epidemiology? Eur Heart J 26(1):5–7CrossRefPubMed

90.

Lavie CJ, Alpert MA, Arena R, Mehra MR, Milani RV, Ventura HO (2013) Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. JACC Heart Fail 1(2):93–102CrossRefPubMed

91.

Lavie CJ, Sharma A, Alpert MA, de Schutter A, Lopez-Jimenez F, Milani RV, Ventura HO (2016) Update on obesity and obesity paradox in heart failure. Prog Cardiovasc Dis 58(4):393–400CrossRefPubMed

92.

Padwal R, McAlister FA, McMurray JJ, Cowie MR, Rich M, Pocock S et al (2014) The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data. Int J Obes 38(8):1110–1114CrossRef

93.

Vest AR, Wu Y, Hachamovitch R, Young JB, Cho L (2015) The heart failure overweight/obesity survival paradox: the missing sex link. JACC Heart Fail 3(11):917–926CrossRefPubMed

94.

Padwal R, Leslie WD, Lix LM, Majumdar SR (2016) Relationship among body fat percentage, body mass index, and all-cause mortality: a cohort study. Ann Intern Med 164(8):532–541CrossRefPubMed

95.

Stokes A, Preston SH (2015) Smoking and reverse causation create an obesity paradox in cardiovascular disease. Obesity 23(12):2485–2490CrossRefPubMed

96.

Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ et al (2010) Body-mass index and mortality among 1.46 million white adults. N Engl J Med 363(23):2211–2219CrossRefPubMed

97.

Joshy G, Korda RJ, Bauman A, Van Der Ploeg HP, Chey T, Banks E (2014) Investigation of methodological factors potentially underlying the apparently paradoxical findings on body mass index and all-cause mortality. PLoS One 9(2):e88641CrossRefPubMedPubMedCentral

98.

Aggarwal R, Harling L, Efthimiou E, Darzi A, Athanasiou T, Ashrafian H (2016) The effects of bariatric surgery on cardiac structure and function: a systematic review of cardiac imaging outcomes. Obes Surg 26(5):1030–1040CrossRefPubMed

99.

Rodriguez Flores M, Aguilar Salinas C, Piché ME, Auclair A, Poirier P (2017) Effect of bariatric surgery on heart failure. Expert Rev Cardiovasc Ther 15(8):567–579CrossRefPubMed

Titel: Obesity cardiomyopathy: the role of obstructive sleep apnea and obesity hypoventilation syndrome
verfasst von: William Newmarch
Madina Weiler
Brian Casserly
Publikationsdatum: 15.01.2019
Verlag: Springer London
Erschienen in: Irish Journal of Medical Science (1971 -) / Ausgabe 3/2019
Print ISSN: 0021-1265
Elektronische ISSN: 1863-4362
DOI: https://doi.org/10.1007/s11845-018-01959-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

23.04.2024 | Ablationstherapie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Obesity cardiomyopathy: the role of obstructive sleep apnea and obesity hypoventilation syndrome

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Drei Mythen bei der Antibiotikatherapie

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2019

Characteristics and in-hospital outcomes of hospitalisations with heart failure with reduced or preserved ejection fraction undergoing percutaneous coronary intervention

Primary total hip arthroplasty: registry data for fixation methods and bearing options at a minimum of 10 years

The clinical characteristics and correlates of lithium toxicity in a tertiary referral centre

Introduction of an academic internship in Ireland: views of undergraduate medical students

Provision of MR imaging for patients with cardiac implantable electronic devices (CIEDs): a single-center experience and national survey

Management of type 1 diabetes in primary schools in Ireland: a cross-sectional survey

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Drei Mythen bei der Antibiotikatherapie

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Update Innere Medizin